University Hospital Cologne

Kutatók

• RBReinhard Büttner

Futó vizsgálatok

• Még nem toboroz

  A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleucel / Zola-cel), CD19-CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis

  NCT07335562· 3. fázis· Juno Therapeutics, Inc., a Bristol-Myers Squibb Company· Forrás

• Még nem toboroz

  IDH1-vac in Patients With Newly Diagnosed IDH1R132H-positive High-grade Astrocytomas

  NCT07888647· 2. fázis· German Cancer Research Center· Forrás

• Még nem toboroz

  A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)

  NCT07915219· 3. fázis· Boehringer Ingelheim· Forrás

• Még nem toboroz

  Comparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk Medulloblastoma

  NCT07291102· 3. fázis· Nationwide Children's Hospital· Forrás

• Még nem toboroz

  Minimally-invasive ICG-guided Retroperitoneal Sentinel Lymph Node Dissection in the Primary Staging of Testicular Cancer Versus Standard of Care

  NCT07699640· Heinrich-Heine University, Duesseldorf· Forrás

• Még nem toboroz

  Stratification and Treatment in Early Psychosis Study -ASSIST

  NCT07326124· 3. fázis· University of Oxford· Forrás

• Még nem toboroz

  A Study of Mirdametinib in Infants and Toddlers With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas

  NCT07850635· 1. fázis· SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany· Forrás

• Még nem toboroz

  Prospective multicenter clinical trial for risk estimation and treatment stratification in low and intermediate risk neuroblastoma patients - NB2015-LR

  2024-517295-37-00· 3. fázis· University Of Cologne· Forrás

• Még nem toboroz

  PD-1 Blockade Alone Versus in Combination With Chemotherapy as First Line Therapy in Females With Advanced NSCLC & PD-L1 Expression ≥50%

  NCT07877584· 3. fázis· German Cancer Research Center· Forrás

• Még nem toboroz

  A Study to Evaluate Adverse Events and Change in Disease Activity With Injected Etentamig Plus Oral Pomalidomide Versus Standard Therapies in Adults With Relapsed or Refractory Multiple Myeloma

  NCT07728188· 3. fázis· AbbVie· Forrás

• Toboroz

  A phase I study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in patients with solid tumors

  2024-518348-19-00· 1. fázis· Novartis Pharma AG· Forrás

• Toboroz

  Cevostamab in Combination With Pomalidomide and Dexamethasone After BCMA- Targeting CAR T-Cell Therapy in Participants With Previously Treated Multiple Myeloma

  NCT07825064· 2. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  A study to test a new drug (TRP-001) given before prostate cancer surgery in patients with very high-risk Prostate cancer.”

  2026-526406-32-00· 1. fázis· Torpedo Pharmaceuticals AG· Forrás

• Még nem toboroz

  Safety and Efficacy of Ruxolitinib in Patients With HNSCC and High NLR Treated With Pembrolizumab - The Phase 2 InflammaSTOP Trial

  NCT07840456· 2. fázis· University Hospital, Basel, Switzerland· Forrás

• Még nem toboroz

  A Study of Lebrikizumab in Adults and Adolescents With Face and Neck Atopic Dermatitis

  NCT07873801· 3. fázis· Almirall, S.A.· Forrás

• Még nem toboroz

  Study of the safety and efficacy of asciminib in pediatric and young adult participants with r/r Ph+ or ABL-class Ph-like ALL

  2025-522019-40-00· 1/2. fázis· Novartis Pharma AG· Forrás

• Toboroz

  A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis

  NCT07412704· 1/2. fázis· Bristol-Myers Squibb· Forrás

• Toboroz

  Stratification and Treatment in Early Psychosis Study - ENHANCE

  NCT06778564· 3. fázis· University of Oxford· Forrás

• Toboroz

  Phase 3 Trial of Tarlatamab (SC vs IV) In Extensive-Stage Small Cell Lung Cancer After Platinum based First-line Chemotherapy (DeLLphi-315)

  2026-525489-23-00· 3. fázis· Amgen Inc.· Forrás

• Toboroz

  A Randomized, Double-Blind, Phase 3 Study of Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D–Mutated Metastatic Pancreatic Ductal Adenocarcinoma (DAWN-303)

  2025-525009-18-00· 3. fázis· Incyte Corp.· Forrás

• Toboroz

  Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02)

  NCT07680790· 3. fázis· Bristol-Myers Squibb· Forrás

• Még nem toboroz

  AIEOP-BFM ALL 2025 - International collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia

  2025-522190-11-01· 3. fázis· Universitaetsklinikum Schleswig-Holstein AöR· Forrás

• Még nem toboroz

  Catheter Ablation for AF in Patients With Severe Mitral Regurgitation After Successful Transcatheter Mitral-Valve Repair

  NCT07380932· Atrial Fibrillation Network· Forrás

• Toboroz

  A Study Evaluating Ficerafusp Alfa (BCA101) QW in Combination With Pembrolizumab vs Alternative Ficerafusp Alfa Dosing in 1L R or M HNSCC

  NCT07807163· 2. fázis· Bicara Therapeutics· Forrás

• Még nem toboroz

  NeoAdjuvant Therapy Comparing Sacituzumab Govitecan+Pembrolizumab vs. SoC Chemotherapy in Clinical Stage II-III, Triple-negative Early Breast Cancer

  NCT07178730· 3. fázis· Women's Cancer Study Group GmbH· Forrás

• Toboroz

  Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy

  2025-524335-39-00· 3. fázis· Gilead Sciences Inc.· Forrás

• Toboroz

  A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease

  NCT07737743· 2. fázis· Novartis Pharmaceuticals· Forrás

• Toboroz

  A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation

  NCT07566052· 3. fázis· Astellas Pharma Global Development, Inc.· Forrás

• Toboroz

  PULSed Field Ablation for Atrial Fibrillation Using a Balloon for Early Intervention - Study

  NCT07621003· Asklepios proresearch· Forrás

• Toboroz

  A trial to learn how safe elecoglipron is and how well it works in adults living with obesity or excess body weight with or without type 2 diabetes

  2025-524688-19-00· 3. fázis· AstraZeneca AB· Forrás

• Toboroz

  Study of Lenacapavir, Teropavimab, and Zinlirvimab in Virologically Suppressed Adults With HIV-1 on Stable Oral Treatment Regimens

  2025-524336-19-00· 3. fázis· Gilead Sciences Inc.· Forrás

• Még nem toboroz

  Modulated Mid-frequency Whole-body Electromyostimulation and Nutritional Therapy in Gastrointestinal Cancer Patients

  NCT06414122· University of Cologne· Forrás

• Toboroz

  A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease

  NCT07688213· 2. fázis· Sanofi· Forrás

• Toboroz

  Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease

  NCT07549698· 1/2. fázis· CRISPR Therapeutics AG· Forrás

• Toboroz

  The RAPID-Elapse study: Can the drug bupropion improve fatigue symptoms in patients with long COVID?

  2025-524443-12-00· 2. fázis· Goethe University Frankfurt· Forrás

• Toboroz

  DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy

  NCT07544654· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  A Clinical Study to Compare BupiZenge With Lidocaine for Pain Due to Oral Mucositis in Patients With Head and Neck Cancer.

  NCT07672236· 3. fázis· OncoZenge AB· Forrás

• Toboroz

  A First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Selected Advanced Solid Tumors

  NCT07600476· 1. fázis· Kupando GmbH· Forrás

• Toboroz

  A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

  NCT07365241· 3. fázis· AbbVie· Forrás

• Még nem toboroz

  PHOENIX - ECP: Extracorporeal PHotopheresis for immune-related cOlitis and/or hEpatitis in advanced melaNoma with inadequate response to steroId eXposure

  2026-526261-14-00· 2. fázis· Therakos Europe Limited· Forrás

• Még nem toboroz

  GMMG-HD11/DSMM XXI/64007957MMY3010

  NCT07671287· 3. fázis· University of Heidelberg Medical Center· Forrás

• Toboroz

  Beamion 44: A Study to Test How Well Zongertinib is Tolerated by People With Advanced Non-small Cell Lung Cancer With HER2 Mutations When Given in Combination With Chemotherapy With or Without Pembrolizumab

  NCT07486817· 2. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction

  NCT07192952· 3. fázis· Bayer· Forrás

• Toboroz

  PREFer

  NCT06916416· 2. fázis· University Of Cologne· Forrás

• Még nem toboroz

  A trial to learn how well AZD0120 works and about its safety in adults with newly diagnosed multiple myeloma

  2025-524014-29-00· 3. fázis· AstraZeneca AB· Forrás

• Toboroz

  Pembro-FLASH

  NCT06045159· 2. fázis· University Of Cologne· Forrás

• Toboroz

  A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

  NCT07285655· 3. fázis· Liquidia Technologies, Inc.· Forrás

• Toboroz

  Rapid Microaxial Flow Pump Support and Escalation in Patients With Myocardial Infarction Associated Cardiogenic Shock and Persistent Need of Hemodynamic Support

  NCT07655479· University Hospital of Cologne· Forrás

• Toboroz

  A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

  NCT07226843· 1. fázis· Eli Lilly and Company· Forrás

• Toboroz

  A Phase 3 Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children with Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders

  2025-523079-44-00· 3. fázis· Ascendis Pharma Endocrinology Division A/S· Forrás

Showing 50 of 329.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Gyermekkori daganatok31 toboroz
• Tüdőrák29 toboroz
• Krónikus limfoid leukémia (CLL)12 toboroz
• Akut limfoid leukémia (ALL)9 toboroz
• HIV-fertőzés9 toboroz
• Máj- és epeúti rák9 toboroz
• Lupus (SLE)8 toboroz
• Mielóma multiplex7 toboroz
• Parkinson-kór7 toboroz
• Szívelégtelenség6 toboroz
• Alzheimer-kór5 toboroz
• Diffúz nagy B-sejtes limfóma (DLBCL)5 toboroz
• Gyomor- és nyelőcsőrák5 toboroz
• Hodgkin-limfóma5 toboroz
• Melanóma5 toboroz
• Petefészekrák5 toboroz
• Akut mieloid leukémia (AML)4 toboroz
• Áttétes emlőrák4 toboroz
• Dermatomyositis and polymyositis (myositis)4 toboroz
• Fej-nyaki daganatok4 toboroz
• Glioblasztóma4 toboroz
• Hasnyálmirigyrák4 toboroz
• Hólyagrák4 toboroz
• Köpenysejtes limfóma4 toboroz
• Magas vérnyomás4 toboroz
• Pitvarfibrilláció4 toboroz
• Policisztás vesebetegség4 toboroz
• Prosztatarák4 toboroz
• Amiloidózis3 toboroz
• Dystonia3 toboroz
• Essential tremor3 toboroz
• Follikuláris limfóma3 toboroz
• Koszorúér-betegség3 toboroz
• Neuroblasztóma3 toboroz
• Rheumatoid arthritis3 toboroz
• Szarkóma3 toboroz
• Szisztémás szklerózis (szkleroderma)3 toboroz
• Tripla negatív emlőrák3 toboroz
• 2-es típusú cukorbetegség2 toboroz
• Aortic aneurysm2 toboroz
• Bronchiectasis2 toboroz
• Hepatitis B (krónikus)2 toboroz
• Időskori makuladegeneráció2 toboroz
• Immune thrombocytopenia (ITP)2 toboroz
• Krónikus mieloid leukémia (CML)2 toboroz
• Mielodiszplasztikus szindróma (MDS)2 toboroz
• Nephrotic syndrome2 toboroz
• Sjögren-szindróma2 toboroz
• Skizofrénia2 toboroz
• Stroke (szélütés)2 toboroz
• Vastagbélrák2 toboroz
• Zsírmáj (MASLD/MASH)2 toboroz
• 1-es típusú cukorbetegség1 toboroz
• ANCA-asszociált vasculitis1 toboroz
• Aortic stenosis1 toboroz
• Atópiás dermatitisz (ekcéma)1 toboroz
• Brain aneurysm1 toboroz
• Brain metastases1 toboroz
• Burkitt lymphoma1 toboroz
• Cisztás fibrózis1 toboroz
• Depresszió1 toboroz
• Elhízás1 toboroz
• Hepatitis C1 toboroz
• Huntington-kór1 toboroz
• Hyperparathyroidism1 toboroz
• IgA-nefropátia1 toboroz
• Krónikus gyulladásos demielinizációs polineuropátia (CIDP)1 toboroz
• Krónikus vesebetegség1 toboroz
• Liver cirrhosis1 toboroz
• Long COVID és ME/CFS1 toboroz
• Méhnyakrák1 toboroz
• Méhtestrák1 toboroz
• Mild cognitive impairment1 toboroz
• Myocarditis1 toboroz
• Neuroendokrin daganatok1 toboroz
• Neurofibromatosis type 11 toboroz
• Pikkelysömör1 toboroz
• Pulmonális artériás hipertónia1 toboroz
• Testicular cancer1 toboroz
• Tuberkulózis1 toboroz
• Turner syndrome1 toboroz
• Vascular dementia1 toboroz

Lezárt vizsgálatok

• Visszavonták

  A Study Evaluating the Efficacy of Xanomeline/Trospium (XT) on Cognitive Impairment After 24 and 52 Weeks of Treatment in Adult Participants With Schizophrenia

  NCT07084831· 3. fázis· European Group for Research In Schizophrenia· Forrás

• Toboroz

  A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

  NCT07630974· 1/2. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  A clinical trial to learn about the effects of VHB937 in people with Alzheimer's disease

  2024-516966-12-00· 2. fázis· Novartis Pharma AG· Forrás

• Fut, nem toboroz

  Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1 Gene Variants (AGLOW)

  NCT07161037· 2. fázis· Vertex Pharmaceuticals Incorporated· Forrás

• Fut, nem toboroz

  Study of zoldonrasib in Previously Treated Patients with RAS G12D-Mutant Non-Small Cell Lung Cancer (NSCLC)

  2025-521681-10-00· 2. fázis· Revolution Medicines Inc.· Forrás

• Fut, nem toboroz

  Zelenectide Pevedotin in NECTIN4 Amplified Advanced or Metastatic Non-small Cell Lung Cancer

  2025-521115-40-00· 2. fázis· Bicycletx Limited· Forrás

• Fut, nem toboroz

  Trial of Sibeprenlimab in the Treatment of Sjögren’s Disease

  2024-516295-14-00· 2. fázis· Otsuka Pharmaceutical Development & Commercialization Inc.· Forrás

• Még nem toboroz

  Epicardial Delivery of XC001 Gene Therapy to Promote Angiogenesis in CAD Patients Undergoing Treatment With CABG

  NCT07118449· 2. fázis· XyloCor Therapeutics, Inc.· Forrás

• Lezárult

  Phase 2b Randomized, Double-Blind Study with Phage for CF Subjects with Pseudomonas Lung Infection

  2024-519856-94-00· 2. fázis· Biomx Ltd.· Forrás

• Lezárult

  Integrated PK/efficacy, safety, and immunogenicity study to demonstrate similarity of JPB898, a proposed biosimilar to nivolumab, to Opdivo® in combination with Yervoy®

  NCT06587451· 3. fázis· H e x a l AG· Forrás

• Fut, nem toboroz

  Study of Eftilagimod Alfa (Efti) in Combination With Pembrolizumab and Chemotherapy Versus Placebo in Combination With Pembrolizumab and Chemotherapy in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) (TACTI-004)

  NCT06726265· 3. fázis· Immutep S.A.S.· Forrás

• Lezárult

  A Phase 1 Study of PRT7732, an Oral SMARCA2 Degrader, in Patients with Advanced or Metastatic Solid Tumors with a SMARCA4 Mutation

  NCT06560645· 1. fázis· Prelude Therapeutics Inc.· Forrás

• Lezárult

  A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Study Participants With Active Psoriatic Arthritis

  NCT06624228· 3. fázis· UCB Biopharma SRL· Forrás

• Lezárult

  A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Moderate to Severe Plaque Psoriasis

  NCT06586112· 3. fázis· Alumis Inc· Forrás

• Fut, nem toboroz

  A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease

  NCT06544616· 2. fázis· Janssen Pharmaceutica N.V., Belgium· Forrás

• Lezárult

  Randomized adaptive assessment of post COVID syndrome treatments (RAPID) Reducing Inflammatory Activity in Patients with post COVID Syndrome (REVIVE)

  2024-511628-16-00· 2. fázis· Goethe University Frankfurt· Forrás

• Lezárult

  Effects of maintenance cabozantinib+BSC versus BSC in children and AYA with osteosarcoma. ( CabOSTar )

  NCT06341712· 2. fázis· Ipsen Innovation· Forrás

• Lezárult

  A Two-Part Study to Assess the Effectiveness, Safety, and Blood Levels of Repeat Doses of Inhaled ETD001 in People with Cystic Fibrosis

  2023-504092-25-00· 2. fázis· Enterprise Therapeutics Limited· Forrás

• Lezárult

  A Phase 1/2 Study of TAS3351 in Patients with Advanced Non-Small Cell Lung Cancer and EGFR Mutations

  NCT05765734· 1/2. fázis· Taiho Oncology Inc.· Forrás

• Lezárult

  A Study to Investigate the Safety and Efficacy of KER-012 in Combination With Background Therapy in Adult Participants With Pulmonary Arterial Hypertension (PAH) (TROPOS).

  NCT05975905· 2. fázis· Keros Therapeutics Inc.· Forrás

• Fut, nem toboroz

  A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With Early Alzheimer's Disease (ALTITUDE-AD)

  NCT06335173· 2. fázis· Acumen Pharmaceuticals· Forrás

• Fut, nem toboroz

  A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)

  NCT06018337· 3. fázis· DualityBio Inc.· Forrás

• Lezárult

  Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)

  NCT05934526· 3. fázis· GB002, Inc.· Forrás

• Lezárult

  A first-in-human trial of safety and efficacy of GEN3017 in subjects with Hodgkin lymphoma or non-Hodgkin lymphoma

  NCT06018129· 1/2. fázis· Genmab A/S· Forrás

• Lezárult

  A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)

  NCT06077864· 3. fázis· Boehringer Ingelheim· Forrás

• Lezárult

  The PEERLESS II Study

  NCT06055920· Inari Medical· Forrás

• Fut, nem toboroz

  [177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer

  NCT05870579· 1. fázis· Novartis Pharmaceuticals· Forrás

• Lezárult

  Proof of Concept Treatment Study of Orally Administered VH4004280 or VH4011499 in HIV-1 Infected Adults

  NCT06039579· 2. fázis· ViiV Healthcare· Forrás

• Fut, nem toboroz

  Phase 2 Placebo-controlled Study to Assess the Safety, Efficacy, and PK of ESK-001 in SLE

  2022-502105-15-00· 2. fázis· Alumis Inc.· Forrás

• Fut, nem toboroz

  A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation

  NCT06045806· 3. fázis· Celgene· Forrás

• Lezárult

  A Study of PRT2527 as Monotherapy and in Combination With Zanubrutinib or Venetoclax in Participants With R/R Hematologic Malignancies

  NCT05665530· 1. fázis· Prelude Therapeutics Incorporated· Forrás

• Lezárult

  A Study Evaluating Pharmacokinetic Similarity of ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Resected Stage III and Stage IV Melanoma in the Adjuvant Setting

  2022-502620-49-00· 1. fázis· Amgen Inc.· Forrás

• Lezárult

  A study to evaluate the safety and efficacy of the tumor-targeting human antibody-cytokine fusion protein L19TNF plus lomustine in patients with glioblastoma at first progression

  NCT03779230· 1/2. fázis· Philogen S.p.A.· Forrás

• Lezárult

  A Phase 3b Multicenter Open-label Trial of the Safety, Tolerability, and Efficacy of Tolvaptan in Infants and Children 28 days to less than 12 weeks of Age with Autosomal Recessive Polycystic Kidney Disease (ARPKD)

  NCT04786574· 3. fázis· Otsuka Pharmaceutical Development & Commercialization Inc.· Forrás

• Fut, nem toboroz

  Durvalumab and Tremelimumab as First Line Treatment in Participants With Advanced Hepatocellular Carcinoma (HCC)

  NCT05883644· 3. fázis· AstraZeneca· Forrás

• Lezárult

  To Investigate Efficacy, Pharmacodynamics, and Safety of BC 007 in Participants With Long COVID

  NCT05911009· 2. fázis· Berlin Cures GmbH· Forrás

• Lezárult

  A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes

  NCT05872620· 3. fázis· Eli Lilly and Company· Forrás

• Lezárult

  An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid Arthritis

  NCT05848258· 2. fázis· Eli Lilly and Company· Forrás

• Lezárult

  Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial – Follow Up Long Term Extension (IMPAHCT-FUL)

  NCT05557942· 3. fázis· Aerovate Therapeutics Inc.· Forrás

• Lezárult

  A Study of AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Group 2

  NCT05737940· 2. fázis· AstraZeneca· Forrás

• Lezárult

  Lenalidomide, Bortezomib and Dexamethasone Induction Therapy With Either Intravenous or Subcutaneous Isatuximab in Patients With Newly Diagnosed Multiple Myeloma

  NCT05804032· 3. fázis· University of Heidelberg Medical Center· Forrás

• Lezárult

  A Phase 2, Open-Label, Multicenter, Basket Study Evaluating the Efficacy of Brexucabtagene Autoleucel in Adults with Rare B-cell Malignancies (ZUMA 25) – Substudy C – Relapsed/Refractory Burkitt Lymphoma (BL)

  2022-501261-46-00· 2. fázis· Kite Pharma Inc.· Forrás

• Lezárult

  A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate Mavacamten in Adults with Cardiomyopathy

  NCT05582395· 3. fázis· Myokardia Inc.· Forrás

• Lezárult

  Vamikibart in Participants With Uveitic Macular Edema

  NCT05642325· 3. fázis· Hoffmann-La Roche· Forrás

• Fut, nem toboroz

  A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast Cancer

  NCT05654623· 3. fázis· Pfizer· Forrás

• Lezárult

  Study to assess safety and identify dose of ribociclib in combination of temozolomide and topotecan (TOTEM) in patients (12 months – 21 years old) with relapsed or refractory solid tumors (Phase I), and further assess efficacy and safety in patients (12 months – 21 years old) with relapsed or refractory neuroblastoma (Phase II)

  NCT05429502· 1/2. fázis· Novartis Pharma AG· Forrás

• Lezárult

  A Study in People With Systemic Sclerosis to Test Whether Avenciguat (BI 685509) Has an Effect on Lung Function and Other Systemic Sclerosis Symptoms

  NCT05559580· 2. fázis· Boehringer Ingelheim· Forrás

• Lezárult

  A Phase 3 Study of Telitacicept for the Treatment of Moderately to Severely Active Systemic Lupus Erythematosus

  NCT05306574· 3. fázis· Remegen Co. Ltd.· Forrás

• Lezárult

  Phase I study of MGY825 in patients with lung cancer

  NCT05275868· 1. fázis· Novartis Pharma AG· Forrás

• Fut, nem toboroz

  Study to Evaluate Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) Long-term Safety and Efficacy in Subjects Without F508del

  NCT05331183· 3. fázis· Vertex Pharmaceuticals Incorporated· Forrás

Showing 50 of 148.

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Tüdőrák95 munka · 58 vizsgálat
• Parkinson-kór68 munka · 10 vizsgálat
• Hodgkin-limfóma47 munka · 15 vizsgálat
• Mild cognitive impairment33 munka · 7 vizsgálat
• Krónikus limfoid leukémia (CLL)27 munka · 26 vizsgálat
• Zöldhályog (glaukóma)18 munka · 1 vizsgálat
• Dystonia18 munka · 3 vizsgálat
• Időskori makuladegeneráció17 munka · 8 vizsgálat
• Aortic stenosis17 munka · 4 vizsgálat
• Brain metastases17 munka · 2 vizsgálat
• Neuroblasztóma17 munka · 6 vizsgálat
• Diffúz nagy B-sejtes limfóma (DLBCL)16 munka · 9 vizsgálat
• Szisztémás szklerózis (szkleroderma)13 munka · 7 vizsgálat
• Pulmonális artériás hipertónia12 munka · 12 vizsgálat
• Aortic aneurysm12 munka · 2 vizsgálat
• Policisztás vesebetegség11 munka · 6 vizsgálat
• Lewy-testes demencia10 munka · 0 vizsgálat
• Nephrotic syndrome8 munka · 2 vizsgálat
• Essential tremor7 munka · 3 vizsgálat
• Peripheral artery disease7 munka · 1 vizsgálat
• Testicular cancer6 munka · 1 vizsgálat
• Spinális izomatrófia (SMA)5 munka · 0 vizsgálat
• Köpenysejtes limfóma4 munka · 10 vizsgálat
• Multiple system atrophy4 munka · 0 vizsgálat
• Tourette syndrome3 munka · 0 vizsgálat